Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Biotechnology Institute I Mas D S L holds a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 1 pending office action. This action is assigned to 1 distinct art unit, which aligns with the company's focus on biotechnology and pharmaceuticals. The prosecution is managed by 1 distinct examiner. This indicates that the company's current patent applications are being reviewed in a very specific technical and administrative context.
WOITACH, JOSEPH T is the busiest examiner for Biotechnology Institute I Mas D S L. This examiner is currently responsible for 1 pending office action. Because the total number of pending office actions is 1, WOITACH, JOSEPH T is managing all of the company's pending matters. This indicates that the current prosecution for Biotechnology Institute I Mas D S L is limited to a single examiner and a single art unit. All current legal developments for this portfolio are tied to the decisions of this one examiner.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WOITACH, JOSEPH T | 1 | 49.5% | +27.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18566761 | DESIGN METHOD OF AN INTRAORAL DEVICE | WOITACH, JOSEPH T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18566761 | DESIGN METHOD OF AN INTRAORAL DEVICE | WOITACH, JOSEPH T | — |
| Art Unit | Apps |
|---|---|
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18566761 | DESIGN METHOD OF AN INTRAORAL DEVICE | WOITACH, JOSEPH T | 1687 | §101§112 | Non-Final OA | — | Pending | Dec 04, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBiotechnology Institute I Mas D S L has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Joseph T Woitach has the most, with 1 of Biotechnology Institute I Mas D S L's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
